The Future of Lung Cancer and the Monarch Endoscopy Platform

Kazuhiro Yasufuku, MD, PhD

*Dr. Yasufuku is the Director of Interventional Thoracic Surgery & Endoscopy at the University of Toronto. *

At the Society of Thoracic Surgery's Tech-Con Meeting, Dr. Yasufuku presented on the novelty of robot bronchoscopy and potential diagnostic and therapeutic applications within thoracic surgery. This presentation marked the first public introduction of the Monarch Platform to a thoracic surgeon audience.

Auris’s goal with the Monarch Platform is to help thoracic surgeons better diagnose and treat lung cancer in the early stages. With traditional, manual bronchoscopy techniques, there is no diagnosis 40% of the time. With the Monarch Platform’s flexible robotics, thoracic surgeons can more easily navigate to difficult-to-reach areas in the periphery of the lung with great precision and accuracy. This may eliminate the need for more invasive procedures to obtain a diagnosis. Early diagnosis of lung cancer can lead to a better prognosis for patients. Current statistics show that more than 90% of those diagnosed with lung cancer do not survive because the disease is typically discovered in more advanced, inoperable stages.

The Society of Thoracic Surgery is the largest organization to represent thoracic and cardiovascular surgeons, with its annual conference bringing together active attendees with educational innovation. Meetings typically feature “interactive learning on hot topics, including thought-provoking lectures from renowned faculty and guests, exciting hands-on sessions, an abundance of networking opportunities, and a chance to view the latest products and services in the specialty.” The Society's 54th Annual Meeting was hosted in Ft. Lauderdale, Florida and gathered more than 4,000 attendees, including approximately 2,200 cardiothoracic surgeons.